- 专利标题: Therapy parameter selection based on ECAP feedback
-
申请号: US15720848申请日: 2017-09-29
-
公开(公告)号: US10933242B2公开(公告)日: 2021-03-02
- 发明人: Nathan A. Torgerson
- 申请人: Medtronic, Inc.
- 申请人地址: US MN Minneapolis
- 专利权人: Medtronic, Inc.
- 当前专利权人: Medtronic, Inc.
- 当前专利权人地址: US MN Minneapolis
- 代理机构: Shumaker & Sieffert, P.A.
- 主分类号: A61N1/36
- IPC分类号: A61N1/36 ; A61B5/04 ; A61B5/07 ; A61B5/00 ; A61B5/16 ; G16H20/30 ; A61B5/12
摘要:
Techniques for therapy delivery are described. A processing circuit may adjust a first therapy parameter from a first level to a second level, and responsive to the adjustment of the first therapy parameter, compare a level of an evoked compound action potential (ECAP) generated from therapy delivery based on the adjusted first therapy parameter to an ECAP threshold. The processing circuit may adjust a second therapy parameter from a third level to a fourth level based on the comparison. The second therapy parameter is different than the first therapy parameter. The processing circuit may cause therapy delivery with the first therapy parameter at the second level and the second therapy parameter at the fourth level.
公开/授权文献
- US20190099601A1 THERAPY PARAMETER SELECTION BASED ON ECAP FEEDBACK 公开/授权日:2019-04-04
信息查询